These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19614802)

  • 1. Intensive monitoring of adherence to treatment helps to identify "true" resistant hypertension.
    de Souza WA; Sabha M; de Faveri Favero F; Bergsten-Mendes G; Yugar-Toledo JC; Moreno H
    J Clin Hypertens (Greenwich); 2009 Apr; 11(4):183-91. PubMed ID: 19614802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
    Siddiqui M; Judd EK; Dudenbostel T; Zhang B; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2019 Sep; 74(3):652-659. PubMed ID: 31327263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
    Siddiqui M; Judd EK; Dudenbostel T; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2020 Feb; 75(2):510-515. PubMed ID: 31813346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial.
    Hosseininasab M; Jahangard-Rafsanjani Z; Mohagheghi A; Sarayani A; Rashidian A; Javadi M; Ahmadvand A; Hadjibabaie M; Gholami K
    Am J Hypertens; 2014 Nov; 27(11):1339-45. PubMed ID: 24771706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
    Kreutz R; Scholze J; Douros A
    Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perception of uncontrolled blood pressure and non-adherence to anti-hypertensive agents in diabetic hypertensive patients.
    Ledur PS; Leiria LF; Severo MD; Silveira DT; Massierer D; Becker AD; Aguiar FM; Gus M; Schaan BD
    J Am Soc Hypertens; 2013; 7(6):477-83. PubMed ID: 23969287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
    Krieger EM; Drager LF; Giorgi DMA; Pereira AC; Barreto-Filho JAS; Nogueira AR; Mill JG; Lotufo PA; Amodeo C; Batista MC; Bodanese LC; Carvalho ACC; Castro I; Chaves H; Costa EAS; Feitosa GS; Franco RJS; Fuchs FD; Guimarães AC; Jardim PC; Machado CA; Magalhães ME; Mion D; Nascimento RM; Nobre F; Nóbrega AC; Ribeiro ALP; Rodrigues-Sobrinho CR; Sanjuliani AF; Teixeira MDCB; Krieger JE;
    Hypertension; 2018 Apr; 71(4):681-690. PubMed ID: 29463627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.
    Grigoryan L; Pavlik VN; Hyman DJ
    J Am Soc Hypertens; 2013; 7(6):471-6. PubMed ID: 23890931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
    Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
    JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic.
    Hameed MA; Tebbit L; Jacques N; Thomas M; Dasgupta I
    J Hum Hypertens; 2016 Feb; 30(2):83-9. PubMed ID: 25947275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study.
    Fleig SV; Weger B; Haller H; Limbourg FP
    Adv Ther; 2018 Mar; 35(3):353-366. PubMed ID: 29498018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. True Resistant Hypertension Following Observed Drug Ingestion: A Systematic Evaluation.
    Bunker J; Chang CL; Chapman N; Poulter N; Thom S; Thornton-Jones L; Sever P
    J Clin Hypertens (Greenwich); 2017 Mar; 19(3):250-255. PubMed ID: 27542974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appraisal of the Knowledge of Hypertensive Patients Regarding Blood Pressure Control and Comorbidities: Results of a French Regional Survey.
    Allibe M; Babici D; Chantrel YF; Lesquerbault B; Dubau M; Fickl R; Takla Z; Preissig-Dirhold C; Bucura R; Sissoko A; Coliban M; Chantrel F
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):365-372. PubMed ID: 27826733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.
    Hayes P; Casey M; Glynn LG; Molloy GJ; Durand H; O'Brien E; Dolan E; Das K; Newell J; Finn D; Harhen B; Conneely A; Murphy AW
    Br J Gen Pract; 2019 Sep; 69(686):e621-e628. PubMed ID: 31358495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
    Corrêa NB; de Faria AP; Ritter AM; Sabbatini AR; Almeida A; Brunelli V; Calhoun DA; Moreno H; Modolo R
    J Am Soc Hypertens; 2016 Jun; 10(6):510-516.e1. PubMed ID: 27161936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.
    Santschi V; Rodondi N; Bugnon O; Burnier M
    Eur J Intern Med; 2008 Oct; 19(6):427-34. PubMed ID: 18848176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.